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Blood-brain barrier (BBB) characteristics are induced and maintained by cross-talk 
between brain microvessel endothelial cells and neighbouring elements of the neurovascular 
unit. While pericytes are the cells situated closest to brain endothelial cells morphologically 
and share a common basement membrane, they have not been used in co-culture BBB models 
for testing drug permeability. We have developed and characterized a new syngeneic BBB 
model using primary cultures of the three main cell types of cerebral microvessels. The co-
culture of endothelial cells, pericytes and astrocytes mimick the anatomical situation in vivo. 
In the presence of both pericytes and astrocytes rat brain endothelial cells expressed enhanced 
levels of tight junction (TJ) proteins occludin, claudin-5 and ZO-1 with a typical localization 
at the cell borders. Further morphological evidence of the presence of interendothelial TJs 
was provided by electron microscopy. The transendothelial electrical resistance (TEER) of 
brain endothelial monolayers in triple co-culture, indicating the tightness of TJs reached 400 
Ω×cm2 on average, while the endothelial permeability coefficients (Pe) for fluorescein was in 
the range of 3×10-6 cm/s. Brain endothelial cells in the new model expressed glucose 
transporter-1, efflux transporters P-glycoprotein and multidrug resistance protein-1, and 
showed a polarized transport of rhodamine 123, a ligand for P-glycoprotein. To further 
characterize the model, drug permeability assays were performed using a set of 19 compounds 
with known in vivo BBB permeability. Good correlation (R2=0.89) was found between in 
vitro Pe values obtained from measurements on the BBB model and in vivo BBB permeability 
data. The new BBB model, which is the first model to incorporate pericytes in a triple co-
culture setting, can be a useful tool for research on BBB physiology and pathology and to test 
candidate compounds for centrally acting drugs. 
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Cell-culture based models have greatly contributed to our knowledge on the physiology, 
pathology and pharmacology of the blood-brain barrier (BBB) (Deli et al., 2005; Cecchelli et 
al., 2007). Since 1973, when the first in vitro model of the BBB was established by the 
successful isolation of brain microvessels (Joó and Karnushina, 1973) several models 
constructed from cultured cells have been developed (Deli, 2007). The mono-cultures of brain 
endothelial cells were replaced by co-culture systems when it was recognized that (i) cerebral 
endothelial cells lose easily their specific characteristics in culture and (ii) the cells of the 
neurovascular unit play an important role in the induction of BBB properties (Abbott et al., 
2006; Cecchelli et al., 2007). The BBB phenotype of brain endothelial cells includes tight 
junctions (TJs) and the lack of pinocytosis and fenestrae restricting passage of solutes and 
cells to the brain, transendothelial transport pathways, metabolic and detoxifying functions 
(Abbott et al., 2006; Neuwelt et al., 2008). By these specialized functions the BBB provides 
ionic homeostasis and nutrients necessary for the proper functioning of the CNS and it 
protects the nervous system from xenobiotics and regulates the level of neuroactive mediators 
(Pardridge, 2002; Abbott et al., 2006; Zlokovic 2008).  
Brain capillary endothelial cells have a dynamic interaction with other neighbouring 
cells, astroglia, pericytes, perivascular microglia and neurons. This cooperation contributes to 
their unique characteristics displaying both endothelial and epithelial features (Joó, 1996; Deli 
et al., 2005; Abbott et al., 2006; Cecchelli et al., 2007). The cross-talk between the cells of the 
neurovascular unit is crucial for the formation and maintenance of a functional BBB (Abbott 
et al., 2006; Zlokovic, 2008). Among these cells, astrocytes were the first to be recognized as 
regulators of brain endothelial characteristics and functions (for reviews see Abbott, 2005; 
Haseloff et al., 2005; Abbott et al., 2006). Astrocytes are able to induce among others the 
formation of interendothelial tight junctions (TJs) (Tao-Cheng et al., 1987), a fundamental 
characteristic of the BBB. A great number of currently used in vitro BBB model is composed 
of co-culture of brain endothelial cells with astrocytes (Deli et al., 2005; Deli 2007; Cecchelli 
et al., 2007). 
Brain pericytes the nearest neighbours of endothelial cells sharing a common basal 
membrane in cerebral capillaries received much less attention so far (Lai and Kuo, 2005). 
Despite their localization and fundamental role in stabilizing brain capillary structure in vivo 
(Hellstrom et al., 2001; Lai and Kuo, 2005), and their possible importance in the development, 
maintenance, and regulation of the BBB (Lai and Kuo, 2005; Zlokovic, 2008) few data are 
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available on the functional significance of pericytes on BBB properties. Pericytes were found 
to be able to tighten the paracellular barrier in cultured brain endothelial cells (Hayashi et al., 
2004; Dohgu et al., 2005) similarly to astrocytes. We have recently performed a systematic 
comparison of 7 different types of BBB models constructed from primary cultures of rat brain 
microvessel endothelial cells, pericytes and astrocytes (Nakagawa et al., 2007). 
Transendothelial electrical resistance (TEER) and permeability for a small water-soluble 
tracer fluorescein were measured to evaluate paracellular transport reflecting TJ function, an 
important parameter of the quality of BBB models (Deli et al., 2005). We confirmed that 
brain pericytes could strengthen the barrier integrity of cerebral endothelial monolayers. It 
was demonstrated that a triple co-culture model consisting of brain endothelial cells and 
pericytes grown on the opposite sides of a porous membrane and cultured in the presence of 
astrocytes was superior in barrier integrity to the other BBB models tested (Nakagawa et al., 
2007). This in vitro BBB model corresponds to the anatomical situation in the cerebral 
microvessels. 
The aim of the present study was the detailed characterization of the new triple co-
culture BBB model. We examined the cytoarchitecture and cellular markers by 
immunofluorescence and electron microscopy, the morphological and functional integrity of 
the paracellular barrier and the presence and function of influx and efflux transporters. Finally 
in vitro drug permeability was tested for 19 compounds on the triple co-culture BBB model 
and compared to in vivo permeability data in the same species.  
 
2. Materials and Methods 
 
All reagents used in the study were purchased from Sigma (St. Louis, MO, USA), 
unless otherwise indicated. Wistar rats were obtained from Japan SLC Inc., (Shizuoka, Japan). 
Balb/c mice were obtained from Charles River Laboratories Japan Inc., (Kanagawa, Japan). 
All animals were treated in strict accordance with the NIH Guide for Care and Use of 
Laboratory Animals (NIH Publications No. 80-23) and as approved by the Nagasaki 
University Animal Care Committee.  
 
2.1. Cell cultures 
 
Primary cultures of rat brain capillary endothelial cells (RBEC) were prepared from 3-
week-old rats, as previously described (Deli et al., 1997). Meninges were carefully removed 
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from forebrains and gray matter was minced into small pieces of approximately 1 mm3 in ice-
cold Dulbecco’s modified Eagle’s medium (DMEM), then dissociated by 25-times of up-and 
down-strokes with a 5-ml pipette in DMEM containing collagenase type 2 (1 mg/ml, 
Worthington, USA), 300 μl DNase (15 μg/ml), gentamycin (50 μg/ml) and then digested in a 
shaker for 1.5 h at 37 °C. The cell pellet was separated by centrifugation in 20 % bovine 
serum albumin (BSA)-DMEM (1000 × g, 20 min). The microvessels obtained in the pellet 
were further digested with collagenase-dispase (1 mg/ml, Roche, Switzerland) and DNase 
(6.7 μg/ml) in DMEM for 1 h at 37 °C. Microvessel endothelial cell clusters were separated 
on a 33 % continuous Percoll (Pharmacia, Sweden) gradient, collected and washed twice in 
DMEM before plating on 35 mm plastic dishes coated with collagen type IV and fibronectin 
(both 0.1 mg/ml). RBEC cultures were maintained in DMEM/F12 supplemented with 10 % 
plasma derived serum (PDS, Animal Technologies, USA), basic fibroblast growth factor 
(bFGF, Roche, Switzerland, 1.5 ng/mL), heparin (100 μg/ml), insulin (5 μg/ml), transferrin (5 
μg/ml), sodium selenite (5 ng/ml) (insulin-transferrin-sodium selenite media supplement), 
gentamycin (50 μg/ml) and puromycin (4 μg/ml) (Perrière et al., 2005) (RBEC medium I) at 
37 °C with a humidified atmosphere of 5% CO2/95 % air, for 2 days. On the third day, the 
cells received a new medium which contained all the components of RBEC medium I except 
puromycin (RBEC medium II). When the cultures reached 80% confluency (4th day in vitro), 
the purified endothelial cells were passaged by a brief treatment with trypsin (0.05 % wt/vol)-
EDTA (0.02 % wt/vol) solution, and used to construct various types of in vitro BBB models 
(Figs. 1 and 4). 
Rat cerebral astrocytes were obtained from neonatal Wistar rats. Meninges were 
removed and cortical pieces mechanically dissociated in astrocyte culture medium (DMEM 
supplemented with 10 % fetal bovine serum). Dissociated cells were seeded into cell culture 
flasks. In order to obtain type 1 astrocytes, flasks with confluent cultures were shaken at 
37 °C overnight. The purity of astrocytes was checked by immunostaining for glial fibrillary 
acidic protein (GFAP), and the cells were used at passage 2.  
Pure cultures of rat cerebral pericytes were obtained by a prolonged, 2-week culture of 
isolated brain microvessel fragments, that contain pericytes beside endothelial cells. The same 
preparations yield primary RBEC after puromycin-treatment. Pericyte survival and 
proliferation was favored by selective culture conditions, using uncoated dishes, and DMEM 
supplemented with 10 % fetal bovine serum and antibiotics. Culture medium was changed 
every 3 days. Pericytes were characterized by their large size and branched morphology, 
positive immunostaining for α-smooth muscle actin, NG2 chondrotitin sulfate proteoglycan 
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and absence of von Willebrand factor and glial fibrillary acidic protein (GFAP) staining. 
Pericytes and astrocytes were frozen in cryo-medium Cellbanker (BCL-1, Zenoaq, Koriyama, 
Japan), and stored at -80 °C until use. 
 
2.2. Construction of in vitro BBB models 
 
The day when the endothelial cells were plated and models were established was 
defined as day zero in vitro (Day 0; Fig. 1). To construct various in vitro models of BBB 
pericytes or astrocytes (1.5×104 cells/cm2) were seeded on the bottom side of the collagen-
coated polyester membrane of the Transwell inserts. The cells were let to adhere firmly for 
overnight, then endothelial cells (1.5×105 cells/cm2) were seeded on the inside or upper side 
of the inserts placed in the well of the 12-well culture plates containing no cells, pericytes or 
astrocytes (Fig. 4). From Day 1 BBB models were maintained in RBEC medium II. 
supplemented with 500 nM hydrocortisone (Hoheisel et al., 1998). Under these conditions, in 
vitro BBB models were established within 3 days after setting of the cells. Seven types of 
BBB models were constructed (Fig. 4; Nakagawa et al., 2007). As negative controls for 
barrier integrity studies, astrocytes and pericytes, which do not form barrier, were cultured on 




To characterize the cultures after washing and fixation brain endothelial cells were 
incubated with anti-von Willebrand factor rabbit polyclonal antibody, astrocytes with anti-
GFAP mouse monoclonal antibody (Progen Scientific Ltd., Mexborough, UK), pericytes with 
anti-NG2 chondrotitin sulfate proteoglycan rabbit polyclonal antibody (Millipore Corp., MA, 
USA). All primary antibodies were used in a dilution 1:100. As secondary antibodies Alexa 
Fluor 488 conjugated donkey anti-rabbit and anti-mouse immunoglobulins (both from 
Invitrogen Corporation, CA, USA) were used in a dilution 1:1000. To counterstain cell nuclei 
TO-PRO-3 Iodide (Invitrogen Corporation, CA, USA) was used in a dilution of 1:400. To 
stain brain endothelial junctional proteins cell monolayers cultured on inserts in the absence 
or presence of glial cells and pericytes were stained for ZO-1 and claudin-5. The cultures 
were washed in PBS and fixed with ethanol (95 v%)-acetic acid (5 v%) for 10 min at - 20 C 
(ZO-1) or with ethanol for 30 min at 4 C (claudin-5). Cells were blocked with 3 % BSA and 
incubated with primary antibodies anti-ZO-1 and anti-claudin-5 (Zymed Laboratories Inc., 
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CA, USA), for 1 h 30 min. Incubation with secondary antibody Cy3-labelled anti-rabbit IgG 
lasted for 1 h. Between incubations cells were washed three times with PBS. Preparations 
were mounted in Gel Mount (Biomeda, USA) and staining was examined by a Zeiss LSM 5 
Pascal Confocal laser scanning microscope (Oberkochen, Germany). 
 
2.4. Electron microscopy 
 
Cells grown on the membrane were fixed with 3 % paraformaldehyde in cacodylate 
buffer (pH 7.5) for 30 min at 4 °C. After washing with cacodylate buffer several times, the 
membranes of the culture inserts with the cells on the two sides were removed from their 
support and placed into 24 -well chamber slide and were postfixed in 1 % OsO4 for 30 min. 
Following washing with distilled water, the cells on the membrane were dehydrated in graded 
ethanol, block-stained with 2 % uranyl acetate in 70 % ethanol for 1 h and embedded in Taab 
812 (Taab; Aldermaston, Berks, UK). Ultrathin sections were cut perpendicularly for the 
membrane using a Leica UCT ultramicrotome (Leica Microsystems, Milton Keynes, UK) and 
examined using a Hitachi 7100 transmission electron microscope (Hitachi Ltd., Tokyo, Japan). 
 
2.5. Evaluation of the barrier integrity 
 
TEER reflecting the flux of mainly sodium ions through cell layers in culture 
conditions was measured by Epithelial-volt-ohm meter and Endohm-12 chamber electrodes 
(World Precision Instruments, USA). TEER of coated, but cell-free filters was subtracted 
from measured TEER values of the models shown as Ω × cm2. The flux of sodium fluorescein 
(Na-F) across endothelial monolayers was determined as previously described (Kis et al., 
2001; Veszelka et al., 2007). Cell culture inserts were transferred to 12-well plates containing 
1.5 ml Ringer-Hepes buffer (136 mM NaCl, 0.9 mM CaCl2, 0.5 mM MgCl2, 2.7 mM KCl, 1.5 
mM KH2PO4, 10 mM NaH2PO4, 25 mM glucose and 10 mM Hepes, pH 7.4) in the lower or 
abluminal compartments. In the inserts (luminal compartment) culture medium was replaced 
by 0.5 ml buffer containing 10 μg/ml Na-F (MW: 376 Da). The inserts were transferred at 5, 
15 and 30 min to a new well containing Ringer-Hepes buffer. The concentrations of the 
marker molecule in samples from the upper and lower compartments were determined by 
fluorescence multiwell plate reader Wallac 1420 ARVO Multilabel Counter (Perkin Elmer, 
USA; excitation: 485 nm, emission: 535 nm). Flux across cell-free inserts was also measured. 
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Transendothelial permeability coefficient (Pe) was calculated as previously described (Deli et 
al., 2005; Veszelka et al., 2007) and as detailed in data analysis. 
 
2.6. Western blotting 
 
Protein samples from brain endothelial cells cultured in the presence or absence of 
pericytes and astrocytes were separated by SDS-PAGE and transferred to nitrocellulose 
(Hybond, GE Healthcare, UK). Non-specific binding sites were blocked by Perfect-Block 
(MoBiTec GmbH, Germany) (1 % w/v) in Tris-buffered saline (TBS; 25 mM Tris, 150 mM 
NaCl, 2 mM KCl, pH 7.4) containing 0.1 % Tween-20. Anti-claudin-5 and anti-occludin 
mouse monoclonal antibodies, anti-ZO-1 rabbit polyclonal antibody (all from Zymed 
Laboratories Inc., CA, USA), anti-Mdr rabbit and anti-MRP1 goat polyclonal antibodies 
(Santa Cruz Biotechnology, Inc., CA, USA), anti-glucose transporter-1 rabbit polyclonal 
antibody (Millipore Corp., MA, USA) were used in a dilution of 1:5000 in blocking solution 
to incubate blots for 1 h at room temperature. Peroxidase-conjugated anti-mouse, anti-rabbit 
and anti-goat immunoglobulins (GE Healthcare, UK) were applied as secondary antibodies. 
Between incubations blots were washed three times with TBS. To reveal immunoreactive 
bands the blots were incubated in ECL Plus reagent following the manufacturers instructions 
(GE Healthcare, UK) and detected by FluorChem SP Imaging System (Alpha Innotech Corp., 
CA, USA). 
 
2.7. Functional assay for P-glycoprotein  
 
Activity of P-glycoprotein was determined by the measurement of the polarity of the 
transport of rhodamine 123, a ligand of P-glycoprotein (Fontaine et al., 1996). In brief, the 
inserts containing the cell layers were gently washed and the flux of 1 μM rhodamine 123 in 
Ringer-Hepes buffer was measured for 1 h at 37C in the luminal-to-abluminal and in the 
opposite abluminal-to-luminal directions. Rhodamine 123 content in both compartments was 
determined by Wallac 1420 ARVO Multilabel Counter (Perkin Elmer, USA; excitation at 485, 
emission at 538 nm). Verapamil (2 μM, 30 min preincubation) was used as a reference P-
glycoprotein inhibitor. 
 
2.8. In vitro drug transport experiments 
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To measure the flux of 19 drugs selected for the study (Table 1) across the endothelial 
and pericyte monolayers cell culture inserts following measurement of TEER were transferred 
to 12-well plates containing 1.5 ml Ringer-Hepes solution in the lower compartments. All test 
compounds were dissolved in DMSO to yield a 1 mM solution, which was further diluted in 
Ringer-Hepes buffer. In the upper or luminal chambers culture medium was replaced by 0.5 
ml Ringer Hepes containing the test compounds at 1 μM concentration. The inserts were 
transferred at 20, 40 and 60 min to a new well containing Ringer-Hepes solution. The 
concentrations of the test molecules in samples from the upper (luminal) and lower 
(abluminal) compartments were determined by high performance liquid chromatography. Pe 
was calculated for each drug as described in data analysis. 
 
2.9. In vivo studies of drug permeability in mice 
The distribution of compounds to brain tissue in vivo was measured using a tissue 
distribution model in mice (Garberg et al., 2005). Five min after the injection of a single dose 
of the compounds in anesthetized mice via tail vein (n=3), blood samples were collected from 
vena cava and the whole brain was removed. The concentration of the compounds in brain 
and plasma samples were measured by liquid chromatography-tandem mass spectrometry 
(LC-MS/MS). The ratio of the concentration in brain and plasma (Kp) was determined for 
each drug. The ratio was then used to calculate the apparent permeability coefficient (Papp), as 
described in section 2.10., presuming that metabolism, back-flux and tissue accumulation are 
negligible at that time point. 
 
2.10. Analysis of permeability data and correlation with in vivo results 
 
Transport was expressed as μl of donor (luminal) compartment volume from which 
the tracer is completely cleared. Transendothelial permeability coefficient (Pe) was calculated 
as previously described (Deli et al., 2005; Veszelka et al., 2007). Cleared volume was 
calculated from the concentration (C) of the tracer in the abluminal and luminal compartments 





(µl) volumeCleared  
The average cleared volume was plotted vs. time, and permeability  surface area product 





PSe divided by the surface area (1 cm
2 for Transwell-12) generated the endothelial 
permability coefficient (Pe; in 10
-6 cm/s).  
The in vivo data were obtained as described in section 2.9. Brain uptake assays were 
performed with the compounds, and in vivo Papp values were calculated from the ratio 
between the concentration in the plasma and brain tissue at 5 min and expressed as cm/s 
(Ohno et al., 1978, Garberg et al., 2005). The capillary surface area value of 240 cm2/g brain 
was used for the calculations (Garberg et al., 2005). 
 
2.11. Statistical analysis 
All data presented are means ± S.E.M. The values were compared using the analysis 
of variance followed by Bonferroni-Dunn test. Changes were considered statistically 
significant at P < 0.05. All experiments were repeated at least three times, and the number of 




3.1. Characterization of the cells of the triple co-culture BBB model by immunfluorescence 
and electron microscopy 
 
Rat brain endothelial cells obtained by the puromycin purification method (Fig. 1; 
Perrière et al., 2005; Veszelka et al., 2007; Nakagawa et al., 2007) grow in non-overlapping 
continuous monolayers and show tightly apposed, elongated, fusiform morphology and 
positive immunostaining for von Willebrand factor, a marker for endothelium (Fig. 2). 
Astroglia cells characterized by GFAP immunostaining are polygonal with long cell processes 
resembling astroytic endfeet and indicating a differentiated phenotype could be also observed 
(Fig. 2). The shape and size of brain microvascular pericytes are very different from the other 
two cell types of the neurovascular unit (Fig. 2). Pericytes in culture spread large with 
irregular projections. They may grow in multiple layers and are positive for pericyte-markers 
NG2 chondroitin sulfate proteoglycan, nestin (data not shown) and α-smooth muscle actin and 
negative for von Willebrand factor and GFAP staining (Fig. 2). When brain endothelial cells 
were cultured in the presence of both pericytes and astrocytes (EPA model Fig. 1) smooth 
luminal membrane, long and oval cell nuclei (Fig. 3A), a great number of mitochondria (Fig. 
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3B), and interendothelial tight junctions (Fig. 3C) could be observed by electron microscopy. 
The cell nuclei of brain pericytes were more round and the cell bodies protruding (Fig. 3D). 
No junctions were present between pericytes (Fig. 3D). Long thin pericytic cytoplasmic 
processes were also typical (Fig. 3E).  
 
3.2. Paracellular permeability of the BBB models 
 
As compared to brain endothelial cell monolayers which received no influence from 
other cells (E00 on Fig. 4), all co-culture models showed higher TEER and lower 
permeability for fluorescein (Fig. 4). Astrocytes (EA0 and E0A) could increase the tightness 
of endothelial monolayers more than two-fold. The effect was higher when astrocytes were 
positioned on the bottom-side of the inserts in the in contact type model EA0. The presence of 
pericytes (EP0 and E0P) elevated the TEER of RBEC by four-fold on culture day 4 (Fig. 4), 
an effect that was significantly higher than that of astrocytes standardly used in BBB models. 
Triple co-culture models (EAP and EPA) were thigher than the double co-culture models as 
reflected by the TEER values. The resistance of EPA model increased up to 354 ± 15 Ω × cm2 
at day 4, the highest value of the seven models tested which significantly differs from all 
other models (Fig. 4). High TEER was observed in the models constructed with pericytes, as 
compared with those without pericytes. In addition, endothelial cells in contact with pericytes 
(EP0, EPA) showed higher TEER than those out of contact with pericytes (E0P, EAP). 
Astrocytes or pericytes do not form any barrier, as reflected by their very low resistance 
which never exceeded 10 Ω × cm2. The paracellular permeability of RBEC monolayers 
measured by the water soluble small marker fluorescein was the highest in endothelial mono-
cultures (E00; 6.6 ± 0.1 × 10-6 cm/s), indicating the leakiest barrier (Fig. 4). The presence of 
astrocytes or pericytes in either double or triple co-culture systems significantly decreased the 
flux of the tracer. A low permeability for Na-F (3.9 ± 0.2 × 10-6 cm/s) could be measured on 
EPA model of the BBB (Fig. 4). 
 
3.3. Expression and localization of interendothelial tight junction proteins in the BBB models 
 
The levels of TJ proteins occludin, claudin-5 and ZO-1 in brain endothelial cells 
cultured in the absence or presence of astrocytes and pericytes were determined by Western-
blot (Fig. 5). The presence of astrocytes and pericytes increased the expression of endothelial 
TJ proteins. The highest relative levels of claudin-5 and ZO-1 were measured in the triple co-
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culture model EPA, the anatomically correct model, and differed significantly from 
endothelial mono-cultures (E00, Fig. 5). Similar tendency could be observed for occludin. 
Examination of brain endothelial monolayers by immunohistochemistry revealed that 
both E00 and EPA models show strong staining for intercellular junction proteins ZO-1 and 
claudin-5 at cell-cell contacts (Fig. 6). In endothelial cells grown in the absence of any 
cellular interaction (E00) irregular, „zipper-like” localization of the TJ proteins could be 
observed. Punctate distribution in the cytoplasm close to the cell junctions was also visible 
(Fig. 6 arrows). In contrast localization of ZO-1 and claudin-5 was more restricted to 
intercellular junctions delineating clearly cell borders in brain endothelial cells grown in the 
triple co-culture (EPA model; Fig. 6 arrowheads). Zipper-like irregularities and cytoplasmic 
localizations were also reduced in these cells. 
 
3.4. Expression of transporters in the triple co-culture model 
 
Brain endothelial cells in the EPA model express the BBB-specific transporter for 
hexoses, glucose transporter-1, revealed by western blotting as a major band at 45 kDa and a 
weaker band of 55 kDa isoform, both described as glucose transporter-1 isoforms in brain 
(Fig. 7; Yu and Ding, 1998). A strong and even distribution of glucose transporter-1 was 
observed in brain endothelial cells by immunohistochemistry. Among the efflux pumps 
present at the BBB Mrp1 was detected as a single immunoreactive band of 190 kDa (Fernetti 
et al., 2001) and P-glycoprotein as a band at 170 kDa (Rao et al., 2005). Both pumps could be 
also visualized in brain endothelial cells by immunohistochemistry (Fig. 7). In addition, the 
functional activity of Pgp was also tested on the EPA model using rhodamine 123 as a ligand. 
The abluminal to luminal (brain-to-blood) transport of the Pgp ligand was 2.5 times higher 
than in the opposite direction, indicating a strong efflux. 
 
3.5. Drug permeability and correlation with in vivo data 
 
The triple co-culture EPA model was further characterized by testing drug 
permeability. For these assays 19 compounds with known permeability properties including 
passive and active transport at the level of BBB were selected (Table 1). All molecules which 
enter the nervous system by lipid-mediated free diffusion and exert a central effect, antipyrin, 
caffeine, carbamazepine, hydroxyzine, phenytoin, propranolol, trazodone and zolpidem 
(indicated as CNS+ drugs) displayed a high Pe (147.36 - 1174.04 × 10
-6 cm/s) when measured 
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on the model (Fig. 8). In contrast, the Pe value of hydrophilic small molecules with passive 
diffusion, like atenolol, or that of efflux pump ligands, like cimetidine, digoxin, epinastine, 
hydrocortisone, hydroxyzine, prazosin, quinidine, sulpiride, verapamil, vinblastine, vincristine, 
that all have low BBB permeability in vivo (indicated as CNS- drugs) was also small when 
tested on the in vitro BBB model (0.44 - 23.51 × 10-6 cm/s; Fig. 8). When the data obtained 
on the in vitro model were compared with in vivo data expressed as Papp for the same 




In the present study we have constructed and characterized a novel BBB model 
consisting of the triple co-culture of primary rat brain endothelial cells, pericytes and 
astrocytes with the aim to produce a tool for research on BBB physiology, pathology and 
pharmacology. 
 
4.1. Development of the in vitro BBB model: methodical considerations 
 
To establish the model three advances in culture techniques have been exploited as 
shown on Fig. 1. (i) The puromycin method (Perrière et al., 2005 and 2007; Calabria et al., 
2006; Veszelka et al., 2007; Nakagawa et al., 2007) was used to obtain pure cultures of rat 
brain endothelial cells on which all further experiments were based. The principle of the 
method is that endothelial cells of cerebral capillaries express much higher amounts of efflux 
pumps especially P-glycoprotein than any other cells in the freshly isolated brain microvessel 
fractions and tolerate the otherwise toxic concentrations of P-glycoprotein ligand drugs while 
non-endothelial cells are eliminated. Puromycin was found to be the best among the P-
glycoprotein ligands to selectively kill contaminating cells during the first 2 days of the 
culture (Perrière et al., 2005). This selection can also favor capillary endothelial cells versus 
those from larger microvessels, and this could lead to tighter monolayers and better BBB 
models (Ge et al., 2005). 
(ii) Glucocorticoid receptor agonists either physiological like corticosterone and 
hydrocortisone or pharmacological like dexamethasone are known to improve the tightness of 
brain endothelial cells and are used in BBB models (for reviews see Deli et al., 2005; Deli, 
2007). Dexamethasone an effective synthetic glucocorticoid hormone strengthens barrier 
properties, increases TEER and decreases Pe for paracellular markers in many models (for 
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reviews see Deli et al., 2005; Deli, 2007). Physiological concentration of hydrocortisone 
considerably improves the barrier properties of porcine cerebral endothelial cells in serum-
free culture conditions (Hoheisel et al., 1998). Corticosterone is the major glucocorticoid 
hormone in rodents not having hydrocortisone, however both corticosterone and 
hydrocortisone are effective in improving paracellular tightness in cultured rat brain 
endothelial cells (Calabria et al., 2006). Hydrocortisone with more potent anti-inflammatory 
properties was more effective enhancer of the barrier properties in rat cerebral endothelial 
monolayers than corticosterone (Calabria et al., 2006). These results are in agreement with 
previous observations that hydrocortisone improved the barrier properties in both rat (Perrière 
et al., 2005) and mouse BBB models (Weidenfeller et al., 2005). Further studies on rat BBB 
models (Perrière et al., 2007; Veszelka et al., 2007; Nakagawa et al., 2007) and our present 
data all confirm the pharmacological effect of hydrocortisone on rat brain endothelial cells.  
(iii) Cell culture inserts enabled the establishment of BBB models using three cell types. 
Previous triple co-culture BBB models used combinations of brain endothelial cells or cell 
lines, astrocytes, neurons, and leukocytes (for review see Deli, 2007). The presence of both 
astrocytes and neurons decreased the paracellular permeability of RBE4 immortalized rat 
brain endothelial cells (Schiera et al., 2005). In a flow-based in vitro BBB model, the 
differentiation of serotonergic neurons was promoted by the endothelial-glial co-culture 
(Stanness et al., 1999). Although the new model characterized in this study is not the first 
BBB model using three cell types, this is the first rat primary culture-based syngeneic model 
that uses brain pericytes and correspponds to the anatomical situation in brain capillaries 
(Nakagawa et al., 2007). 
 
4.2. The role of pericytes in the induction of BBB properties 
 
Pericytes are crucial in the angiogenesis of the nervous system. Growing microvessels 
of the human telencephalon are formed by a pericyte-driven angiogenic process in which the 
endothelial cells are preceded and guided by migrating pericytes (Virgintino et al., 2007). 
Pericytes also contribute to the maturation and maintenance of BBB properties (for review see 
Lai and Kuo, 2005). Pericytes form direct interdigitating contacts with vascular endothelial 
cells in vivo and there is a clear correlation between higher ratio of pericytes versus 
endothelial cells in blood vessels and the tightness of the endothelial barrier (Allt and 
Lawrenson, 2001). The barrier tightening effect of pericytes was demonstrated on in vitro 
BBB models (Hayashi et al., 2004; Dohgu et al., 2005; Nakagawa et al., 2007). Pericytes were 
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found the be even more effective inducers than astrocytes of paracellular tightness in primary 
rat brain endothelial cells (Nakagawa et al., 2007). While several observations found that 
pericytes or extracellular matrix from pericytes (Hartmann et al., 2007) improve the tightness 
of brain endothelial cells, interestingly, pericyte-endothelial interaction increased matrix 
metalloproteinase-9 secretion and did not improve barrier tightness in a porcine BBB model 
(Zozulya et al., 2008). The differences between species, the models and the culture conditions 
including the preparation of pericyte cultures may explain the dissimilar results. 
Pericytes used in our study were derived from the same brain microvessel fraction from 
which endothelial cells were obtained, but they were cultured separately in conditions 
favoring pericyte growth. The morphology of brain pericytes revealed by light and electron 
microscopy was typical for this cell type (Dore-Duffy, 2008). While smooth muscle cells can 
also express α-smooth muscle actin, the expression of markers NG2 chondroitin sulfate 
proteoglycan and nestin are indicative for brain pericytes (Dore-Duffy, 2008). These pericytes 
together with astrocytes in the presence of hydrocortisone induced in the puromycin-purified 
primary brain microvascular endothelial cells a cytoarchitecture typical for the BBB. The 
tightly apposed, elongated, fusiform cells expressing the endothelial marker von Willebrand 
factor grew in monolayers in a contact inhibited fashion and were connected by tight junction. 
Glucocorticoids can exert a direct action on endothelial cells by switching endothelial 
morphology from larger, cobblestone appearance to smaller spindle shape and increasing 
endothelial cell density via an anti-apoptotic effect (Calabria et al., 2006). In addition, an 
indirect glucocorticoid effect has been suggested through astrocytes and brain pericytes by 
upregulation of angiopoietin-1 and downregulation of VEGF resulting in the stabilization of 
barrier properties at the BBB (Kim et al., 2008). 
 
4.3. Characterization of BBB properties in the new triple co-culture model 
 
The paracellular permeability of the new model with TEER of 350-600 Ω×cm2 
(measured on a 1 cm2 surface with a standard, commercially available instrument; results 
from more than 40 preparations and 600 filters during a period of 2 years) and fluorescein Pe 
between 1.8 - 4  10-6 cm/s is more restrictive than any cell line based BBB model and is 
among the best primary cell based BBB models (for reviews see Deli et al., 2005 and Deli, 
2007). Although higher TEER and, or lower Pe values were described for some bovine and 
porcine models (Zenker et al., 2003; Hoheisel et al., 1998), they have not been extensively 
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characterized for drug permeability except for the bovine brain endothelial cell and rat glia 
co-culture model (Cecchelli et al., 2007). 
Brain endothelial cells in the triple co-culture EPA model, which shows the tightest 
paracellular barrier for ions and fluorescein among the seven models tested in our 
experiments, expressed the highest level of TJ proteins occludin, claudin-5 and ZO-1. The 
localization of claudin-5 and ZO-1 was also more restricted to the interendothelial junctions 
in the EPA model than in brain endothelial cells cultured alone. The higher expression and 
junctional localization of claudin-5 is especially important in the new model, because this TJ 
protein is the only one so far which has been directly linked to restricted BBB permeability in 
vivo (Nitta et al., 2003). Angiopoietin-1 is a likely candidate molecule to mediate this effect, 
because it is upregulated in both pericytes and astrocytes by glucocorticoid treatment (Kim et 
al., 2008) and pericyte-derived angiopoietin-1 enhanced occludin gene expression in a brain 
endothelial cell line (Hori et al., 2004).  
In addition to the induction of barrier properties the presence of the influx transporter 
proteins Glut-1 and the efflux transporters Mrp-1 and Pgp was demonstrated in the new model. 
These transporters are crucial for the nutrient transport and for the extrusion of drugs at the 
BBB (Pardridge, 2002; Abbott et al., 2006; Zlokovic, 2008). The polarity of the Pgp efflux 
pump activity was also demonstrated in a functional assay in the triple model. Astrocytes, 
pericytes and hydrocortisone may all contribute to the expression of BBB transporters in brain 
endothelial cells. It has been demonstrated earlier, that cerebral endothelial cells when 
cultured alone lose the expression of efflux transport proteins and this can be reversed by co-
culture with astrocytes (Berezowski et al., 2004). In the same study the mRNA expression of 
MRP6 efflux pump was up-regulated in bovine brain endothelial cells by pericytes 
(Berezowski et al., 2004). Rat pericytes also enhanced P-glycoprotein activity in a mouse 
brain endothelial cell line, MBEC4 (Dohgu et al., 2005). Astrocytes, hydrocortisone and 
cyclic AMP increased the transcript level of Glut-1, Mdr1a (Pgp), Mrp3, Mrp4 and Bcrp in rat 
brain endothelial cells (Perrière et al., 2007).  
 
4.4. Drug permeability test on the new BBB model 
 
The pharmaceutical industry needs reliable in vitro BBB models for predicting BBB 
permeability of CNS drugs. Any in vitro model to serve as a permeability screen should 
display a restrictive paracellular pathway, a physiologically realistic cell architecture and 
functional expression of transporter mechanisms (Gumbleton and Audus, 2001). As we could 
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demonstrate, the new model possesses all these criteria. A further advantage of the rat BBB 
model is that it can be easily compared to in vivo results and measurements, and it is simple to 
construct syngenic cultures. We tested the drug permeability of the new model with a set of 
19 compounds, the largest set ever tested on primary cell-based in vitro rat BBB model. From 
the results it was possible to discriminate between passively and actively distributed drugs, 
compounds with good penetration to the CNS and ligands of efflux transporters. Moreover, a 
good correlation, R2 = 0.89, was obtained when data from the in vitro model were compared 
with in vivo data.  
The only rat BBB model which has been tested for 22 compounds in a comparative 
study, is an SV40-immortalized rat brain endothelial cell line called SV-ARBEC (Garberg et 
al., 2005). The TEER values of monolayers were only 50-70 Ω × cm2, correlation between in 
vitro and in vivo permeability coefficients was low and the model could not distinguish 
between passively and actively distributed compounds. Our results compare favorably to the 
best BBB model tested in that study, bovine brain endothelial cells cultured with rat glia cell, 
which also could discriminate between passively transported compounds and substrates of 
active efflux (Garberg et al., 2005) and gave high correlation between in vivo and in vitro 




In vitro reconstituted BBB models are important research implements to study the 
structural and functional organization of the BBB under physiological and pathological 
conditions. Furthermore pharmacological studies on reliable and reproducible in vitro BBB 
models can accelerate the research and development of new drugs with better brain 
penetration. The syngeneic rat BBB model established and characterized in this study could 
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Legend to Figures 
 
Fig 1 Schematic drawing of the preparation of the in vitro BBB model. Rat brain endothelial 
cells (RBEC) are isolated 4 days before the establishement of the co-culture system. To purify 
cultures cells are kept in the presence of puromycin for two days. Rat astrocytes are seeded at 
the bottom of 12-well plates, while rat brain pericytes at the filter membranes of inverted cell 
culture inserts the day before the start of the co-culture. On day 0 RBECs are added to the 
luminal compartment of the inserts having pericytes on the other side and positioned in the 
12-well plates containing the astrocytes. From day 1 cells are grown in culture medium 
containing 500 nM hydrocortisone. Experiments were performed on day 4. 
 
Fig. 2 Characterisation of primary cultures by immunofluorescence microscopy. Brain 
endothelial cells express factor VIII-related antigen/von Willebrand factor, while astrocytes 
are positive for glial fibrillary acidic protein (GFAP). Pericytes give a positive 
immunostaining for α-smooth muscle actin and NG2, markers of brain pericytes while are 
negative for endothelial or glial markers. Bar=50 μm. 
 
Fig. 3 Transmission electron microscopy images of brain endothelial cells (A, B, C) and brain 
pericytes (D, E) grown in the triple co-culture model on the two sides of the filter membrane 
of Transwell inserts, marked on pictures as membrane. Brain endothelial cells show typical 
morphology with oval nucleus (A), many mitochondria (A, B) and tight intercellular junctions 
(C). There are now junctions between pericytes which have more round cell bodies and nuclei 
(D) but also long thin processes (E). Bar=600 nm. 
 
Fig. 4 Transendothelial electrical resistance (TEER, expressed as Ω × cm2) and endothelial 
permeability coefficient for sodium fluorescein (Na-F Pe, expressed in 10
-6 cm/s) of the 
different blood-brain barrier models constructed from brain endothelial cells (E), astrocytes 
(A) and pericytes (P). All data are presented as means ± S.E.M. (n=8). Statistically significant 
differences (P < 0.05) in TEER are indicated compared to E00 (a), EA0 (b), E0A (c), EP0 (d), 
E0P (e) and EAP (f), whereas these in Pe are indicated compared to E00 (A), E0A (B),  
respectively. 
 
Fig. 5 Expression of the tight junction integral membrane proteins occludin and claudin-5, 
and the cytoplasmic tight junction protein zonula occludens-1 (ZO-1) in different blood-brain 
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barrier models detected by Western blot. The relative level of the proteins was determined by 
densitometry. Brain endothelial cells were kept in co-culture with astrocytes in contact (EA0) 
or out of contact (E0A), with pericytes in contact (EP0) or out of contact (EPA), or with both 
pericytes and astrocytes (EAP, EPA).  
 
 
Fig. 6 Immunofluorescent staining of confluent brain endothelial cell monolayers alone (E00) 
and in triple co-culture (EPA) for tight junction proteins ZO-1 and claudin-5. Arrows show 
zipper-like staining between endothelial cells in the E00 model, while the junctional 
immunostaining of endothelial cells in co-culture (EPA) forms a continuous, smooth, 
pericellular, belt-like pattern (arrowheads). Bar=20 μm. 
 
Fig. 7 Expression of the influx transporter protein glucose transporter-1 (GLUT1) and the 
efflux transporters multidrug resistance protein-1 (Mrp1) and P-glycoprotein (Pgp) in brain 
endothelial cells cultured in the presence of brain pericytes and astrocytes (EPA model) by 
Western blot and immunohistochemistry. The function of Pgp was tested by the transport of 
its ligand rhodamine 123 (R123) in the apical to basolateral (A to B) and basolateral to apical 
(B to A) directions. 
 
Fig. 8 Endothelial permeability coefficients of drugs tested at the in vitro blood-brain barrier 
model (in vitro Pe) consisting of brain endothelial cell monolayers cultured in the presence of 
brain pericytes and astrocytes. Drugs with known penetration to the central nervous system 
(CNS +) and with low permeability across the BBB and no central effects (CNS -) were 
selected. 
 
Fig. 9 Correlation between endothelial permeability coefficients of drugs tested at the in vitro 
blood-brain barrier model (brain endothelial cell monolayers cultured in the presence of brain 
pericytes and astrocytes, EPA model) (in vitro Pe) and the apparent permeability coefficients 
of the same drugs measured in animal models (in vivo Papp). 
 
Table 1 List of the drugs selected for transport study across brain endothelial cell monolayers 
cultured in the presence of brain pericytes and astrocytes (EPA model). Drugs with known 
penetration to the central nervous system (CNS +) are mostly lipophilic and cross brain 
endothelial cell membranes by lipid-mediated free diffusion. Drugs with low permeability 
 25
across the BBB and no central effects (CNS -) are actively extruded by brain endothelial 
efflux transporters. BCRP, brain cancer resistance protein (ABCG2); MRP-1, multidrug 
resistance protein-1 (ABCC1); MRP-2, multidrug resistance protein-2 (ABCC2); OATP2, 
organic anion transporting polypeptide-2 (SLCO1B1); OCT, organic cation transporter 




Name MW CNS Transport 
Pe 
(10-6cm/s) 
 antipyrin 188 +  passive lipophilic  222.51
 atenolol 226 -  passive hydrophilic 2.49
 caffeine 212 +  passive lipophilic  496.67
 carbamazepine 236 +  passive lipophilic  198.53
 cimetidine 252 -  efflux: Pgp, BCRP, OCT1-3, OCTN-1  2.99
 digoxin 781 -  efflux: Pgp, Oatp2  0.44
 epinastine 286 -  efflux: Pgp  1.87
 hydrocortisone 362 -  efflux: Pgp 5.67
 hydroxyzine 448 +  passive lipophilic  1174.04
 phenytoin 252 +  passive lipophilic  326.73
 prazosin 420 -  efflux: BCRP, Pgp 22.91
 propranolole 296 +  passive lipophilic  1987.16
 quinidine 783 -  efflux: Pgp, OCT-1  7.54
 sulpiride 341 -  efflux: Pgp, influx: OCTN-1, -2, PEPT1 4.39
 trazodone 408 +  passive lipophilic  333.61
 verapamil 491 -  efflux: Pgp, OCT1-3, OCTN-1 23.51
 vinblastine 909 -  efflux: Pgp, MRP-1, -2  3.20
 vincristine 923 -  efflux: Pgp, MRP-1, -2 6.32
 zolpidem 382 +  passive lipophilic  147.36
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